Franklin Resources Inc Akero Therapeutics, Inc. Transaction History

Franklin Resources Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$17.76 - $31.18 $181,116 - $317,973	-10,198 Reduced 46.78%	11,601 $293,000
Q4 2023 Feb 09, 2024	SELL	$11.38 - $50.33 $12,438 - $55,010	-1,093 Reduced 4.77%	21,799 $509,000
Q3 2023 Nov 13, 2023	BUY	$41.19 - $52.25 $191,409 - $242,805	4,647 Added 25.47%	22,892 $1.16 Million
Q2 2023 Aug 11, 2023	BUY	$36.89 - $56.88 $673,058 - $1.04 Million	18,245 New	18,245 $851,000

190

73.8M

241K

647K

Ticker AKRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,417,600
Market Cap $1.45B
Description
Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

Stay updated on Franklin Resources Inc with notifications on news.